Results 221 to 230 of about 6,298,979 (361)

Refractory Status Epilepticus Treated With Bilateral Pulvinar Deep Brain Stimulation—A Case Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT New‐onset refractory status epilepticus (NORSE) arises without an identifiable cause or prior epilepsy history, with a 16%–27% mortality rate and significant long‐term neurological sequelae. Neuromodulation such as deep brain stimulation (DBS) targeting the anterior and centromedian thalamic nuclei has shown promise when the traditional ...
Mengxuan Tang, Amerta Bai, Felipe Rodridgues Marques Ferreira, Sandipan Pati, Thaddeus Walczak, Benjamin Miller, Oladi Bentho, Thomas Henry, Ilo Leppik, Minoo Shams, Zhiyi Sha, Zachary Sanger, Theoden I. Netoff, Thomas Lisko, Anant Naik, Robert McGovern III, Sima Patel   +16 more
wiley   +1 more source

Coordinated Radio Emitter Detection Process Using Group of Unmanned Aerial Vehicles. [PDF]

Sensors (Basel)
Mazuro M, Skokowski P, Kelner JM.
europepmc   +1 more source

Book Review: MacLeish, Kenneth T. 2013. Making War at Fort Hood: Life and Uncertainty in a Military Community. Princeton, NJ: Princeton University Press [PDF]

, 2015
Flecchia, Samantha
core   +2 more sources

The spectrum of schizophrenia [PDF]

Postgraduate Medical Journal, 1988
openaire   +2 more sources

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky, Cara Joyce, H. Jeremy Bockholt, Paul A. Rudnick, William H. Adams, Fiona McAllister, Justin W. Smock, Michael A. Newton, Jane S. Paulsen   +8 more
wiley   +1 more source

Correction: Novel small molecule derivatives improve survivability in the cellular model of Huntington's disease <i>via</i> improving mitochondrial fusion. [PDF]

RSC Med Chem
Kodam P, Kumar V, Pattanayak P, Vitta P, Chatterjee T, Maity S.   +5 more
europepmc   +1 more source

Medicine on the spectrum

eClinicalMedicine, 2022
openaire   +2 more sources

Evaluation of the Efficacy and Safety of Satralizumab in a Pregnant NMOSD Patient With AQP4/MOG‐IgG Dual Seropositive: A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune neuroinflammatory disease, typically characterized by antibodies against aquaporin 4 (AQP4‐IgG) or myelin oligodendrocyte glycoprotein (MOG‐IgG). Simultaneous seropositivity for both antibodies in a single patient is exceedingly rare.
Yeting Luo, Shuhua Xie, Xianghong Liu
wiley   +1 more source

Automated metabolite formula ranking using formula subset analysis for LC-MS/MS-based metabolomics. [PDF]

Metabolomics
Lynn KS.
europepmc   +1 more source

Book Review: Bourgois, Philippe, and Jeff Schonberg. 2009. Righteous Dopefiend. Berkeley: University of California Press [PDF]

, 2015
Kapstad, Christian
core   +2 more sources